Multiple Assemblies exist for SMTL entry 4qev
Crystal structure of BRD2(BD2) mutant with ligand ME bound (METHYL (2R)- 2-[(4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4H-[1,2,4]TRIAZOLO[4,3-A][1, 4]BENZODIAZEPIN-4-YL]PROPANOATE); X-RAY DIFFRACTION 1.80 Å

SMTL ID
4qev.1
Ligands
METHYL (2R)-2-[(4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4H-[1,2,4]TRIAZOLO[4,3-A][1,4]BENZODIAZEPIN-4-YL]PROPANOATE; NONAETHYLENE GLYCOL; NICKEL (II) ION; GLYCEROL
Polypeptides
Bromodomain-containing protein 2
Oligo-state
monomer
SMTL ID
4qev.2
Ligands
METHYL (2R)-2-[(4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4H-[1,2,4]TRIAZOLO[4,3-A][1,4]BENZODIAZEPIN-4-YL]PROPANOATE; NONAETHYLENE GLYCOL; NICKEL (II) ION; GLYCEROL
Polypeptides
Bromodomain-containing protein 2
Oligo-state
homo-dimer
SMTL ID
4qev.3
Ligands
METHYL (2R)-2-[(4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4H-[1,2,4]TRIAZOLO[4,3-A][1,4]BENZODIAZEPIN-4-YL]PROPANOATE; NONAETHYLENE GLYCOL; NICKEL (II) ION; GLYCEROL
Polypeptides
Bromodomain-containing protein 2
Oligo-state
homo-dimer